Press Releases | DEA.gov
Pasar al contenido principal
U.S. flag

Un sitio oficial del Gobierno de Estados Unidos

Así es como usted puede verificarlo

Dot gov
Los sitios web oficiales usan .gov
Un sitio web .gov pertenece a una organización oficial del Gobierno de Estados Unidos.
Https

Los sitios web seguros .gov usan HTTPS
Un candado ( Candado Un candado cerrado ) o https:// significa que usted se conectó de forma segura a un sitio web .gov. Comparta información sensible sólo en sitios web oficiales y seguros.

  • Quiénes somos
    • Sobre la DEA
    • Mission
    • Leadership
    • Nuestra historia
    • Divisiones Nacionales
      • Operational Divisions
    • DEA Museum
    • Wall of Honor
    • Contáctenos
      • Submit a Tip
      • Extortion Scam
      • Public Affairs
      • Social Media Directory
  • Recursos
    • Cartels
    • Illegal Online Pharmacies
    • OD Justice
    • Fentanyl Supply Chain
    • Pill Press Resources
    • Recovery Resources
    • Together for Families
    • Ley de Libertad de Información
      • Fee Waiver
    • Publications
    • Galerías Multimedia
    • Programa de Asistencia a Testigos para Víctimas
      • Human Trafficking Prevention

United States Drug Enforcement Administration

  • Recibir Actualizaciones
  • Scam Alert
  • Menú Completo
  • English
  • Español

Main Menu

Explore DEA
  • Quiénes somos
    • Sobre la DEA
    • Mission
    • Leadership
    • Nuestra historia
    • Divisiones Nacionales
    • DEA Museum
    • Wall of Honor
    • Contáctenos
  • Recursos
    • Cartels
    • Illegal Online Pharmacies
    • OD Justice
    • Fentanyl Supply Chain
    • Pill Press Resources
    • Recovery Resources
    • Together for Families
    • Ley de Libertad de Información
    • Publications
    • Galerías Multimedia
    • Programa de Asistencia a Testigos para Víctimas

Press Releases

Advanced Search

Enter Keywords Below

Filter Results

Select To Narrow Search Results

Year

  • 2025 (17)
  • 2024 (21)
  • 2023 (47)
  • 2022 (65)
  • 2021 (56)
  • 2020 (8)
  • 2019 (6)
  • 2018 (1)
  • 2017 (2)
  • 2003 (1)

Subject

  • Drug Trafficking (465)
  • Synthetic drugs (112)
  • Seizures (Drugs/Property) (105)
  • Guns/Weapons (101)
  • Guilty Plea (100)
  • Arrests/Convictions - Major (87)
  • Major Law Enforcement Operation (86)
  • OCDETF/Task Force (78)
  • Task Forces/Task Force Officers (77)
  • Prescription Drugs (70)
  • Overdose (58)
  • Take Back Day (44)
  • Gangs (41)
  • Money Laundering (35)
  • Outreach/Drug Prevention (34)
  • Diversion Division (32)
  • Fake Pills (29)
  • Narcoterrorism (22)
  • HIDTA (17)
  • Press Conferences (16)
  • Extraditions (14)
  • Prevention/Education - DEA websites GSAD, JTT etc (13)
  • Public and Media Affairs - also see Congressional Affairs (12)
  • Dark Web- Internet Trafficking (11)
  • International/Foreign Operations (11)
  • Red Ribbon (7)
  • Asset Forfeiture (5)
  • Critical Incident (3)
  • Intergovernmental Affairs (2)
  • Intelligence Division - Intelligence Products (1)
  • Scam Calls (1)
  • Terrorism (1)
  • Pharmaceuticals/Pharmacists/Physicians (56)

Drug Name

  • Opioids (19)
  • Oxycodone (16)
  • Fentanyl (9)
  • Synthetic Opioids (8)
  • Morphine (3)
  • Benzodiazepines (2)
  • Hydromorphone (2)
  • Ketamine (2)
  • Steroids (2)
  • Amphetamines (1)
  • Cocaine (1)
  • Heroin (1)
  • Methadone (1)
  • Methamphetamine (1)

Field Division

  • Washington, DC (15)
  • St. Louis (8)
  • Dallas (6)
  • New York (5)
  • Miami (4)
  • Chicago (3)
  • Houston (3)
  • Atlanta (2)
  • El Paso (2)
  • Seattle (2)
  • Los Angeles (1)
  • New Jersey (1)
  • Philadelphia (1)
  • San Diego (1)
  • San Francisco (1)
  • Sede (1)
Clear All Results
PRESS RELEASE

Dark Web Vendor of Opioids and Counterfeit U.S. Currency Pleads Guilty

Mayo 12, 2021
ALEXANDRIA, Va. – A Utica, New York man pleaded guilty yesterday to charges relating to his sale of over $1.2 million in opioid pills and counterfeit U.S. currency on multiple dark web criminal marketplaces. According to court documents, from around October 2016 through February 2021, Albie Pagan, 65, operated under...
Mayo 12, 2021
PRESS RELEASE

Prison healthcare company agrees to $215,000 settlement relating to Controlled Substances Act claims

Marzo 30, 2021
ALBUQUERQUE, N.M. – Acting U.S. Attorney for the District of New Mexico Fred J. Federici has announced that Centurion Correctional Healthcare New Mexico has agreed to a $215,000 settlement relating to civil claims brought by the Department of Justice on behalf of the United States Drug Enforcement Administration (DEA). Centurion...
Marzo 30, 2021
PRESS RELEASE

Albuquerque company agrees to $240,000 settlement relating to Controlled Substances Act claims

Marzo 30, 2021
ALBUQUERQUE, N.M. – Acting U.S. Attorney for the District of New Mexico Fred J. Federici has announced that Albuquerque Health Services (AHS) has agreed to a $240,000 settlement relating to civil claims brought by the Department of Justice on behalf of the United States Drug Enforcement Administration (DEA). AHS operates...
Marzo 30, 2021
PRESS RELEASE

San Antonio Physician Agrees to Pay $350,000 to Resolve Allegations that he Pre-Signed Prescriptions and Issued Prescriptions Without Appropriate Examinations

Marzo 09, 2021
SAN ANTONIO - Doctor Hugo A. Rojas, owner of Hugo A. Rojas, M.D., P.A., and Family Clinics of San Antonio, has agreed to pay $350,000.00 under a civil settlement to resolve allegations he violated certain provisions of the Controlled Substances Act (CSA) and the False Claims Act (FCA), announced Drug...
Marzo 09, 2021
PRESS RELEASE

Justice Department files lawsuit against Creve Coeur pharmacist for Controlled Substances Act violations

Febrero 24, 2021
ST. LOUIS – In a complaint filed February 23, 2021, by the U.S. Attorney’s Office for the Eastern District of Missouri, the government alleges Elizabeth Dembo unlawfully dispensed controlled substances to patients during her time as the pharmacist-in-charge of Olive Street Pharmacy, LLC. The retail pharmacy is located in the...
Febrero 24, 2021
PRESS RELEASE

Pharmaceutical Distributor Vistapharm, Inc. Agrees To Pay $325,000 To Resolve Alleged Violations Of The Controlled Substances Act

Febrero 02, 2021
TAMPA, Fla. - Vistapharm, Inc. has agreed to pay the United States $325,000 to resolve allegations that Vistapharm violated the Controlled Substances Act (CSA) by failing to maintain records required by the CSA. In addition to paying a civil penalty, Vistapharm has agreed to sign separately a Memorandum of Agreement...
Febrero 02, 2021
Showing 51 - 56 of 56 results

Paginación

  • Primera página «
  • Página anterior ‹
  • Página 1
  • Página 2
  • Página 3
  • Página 4
  • Página 5
  • Current page 6
  • Quienes Somos
    • Sobre
    • Contáctenos
    • Museo DEA
  • Recursos
    • Ley de Libertad de Información (FOIA)
    • Publicaciones
    • Galerías Multimedia
    • Programa de Asistencia a Testigos para Víctimas
  • Políticas
    • Accesibilidad, Complementos y Política
    • Políticas Legales y Descargos de Responsabilidad
    • Antidiscriminación y Represalias Acto
    • Política de Privacidad
    • Política de Igualdad de Oportunidades en el Empleo del U.S. DOJ
    • USA.gov
    • Protección de Denunciantes
    • Your Rights as a Federal Employee

United States Drug Enforcement Administration

DEA.gov is an official site of the U.S. Department of Justice
Facebook X LinkedIn Instagram

DEA Contact Center

(202) 307-1000 info@dea.gov
Contact the Webmaster